Fourier-domain optical coherence tomography (OCT) was used to image the three-dimensional (3D) structures of the proliferative membrane in proliferative diabetic retinopathy. The case of a 51-year-old ...

EyePoint Pharmaceuticals, Inc.’s EYPT share price has dipped by 15.13%, which has investors questioning if this is right time to buy.

Ferroptosis is associated with various diseases, but the relationship with diabetic retinopathy(DR ... Neovascularization is one of the critical features of PDR. Occlusion of retinal microvessels can ...

James analyst Dane Leone maintained a Strong Buy rating and a $19.00 price target on Ocular Therapeutix (NASDAQ:OCUL), aligning with the broader analyst consensus. According to InvestingPro data, ...

proliferative diabetic retinopathy; RA, rheumatoid arthritis; ADSCs, adipose-derived mesenchymal stem cells; VSMCs, vascular smooth muscle cells; NFATc2, nuclear factor of activated T cells 2; CCL23, ...

Diabetic vitreous hemorrhage is linked to neuropathologic changes in specific brain regions, as identified by voxel-based ...

Parapapillary outer temporal retina thickening can reveal diabetic retinopathy development in children with type 1 diabetes mellitus.

The FDA has approved Susvimo (ranibizumab injection) for the treatment of patients with diabetic macular edema.

BEDFORD, Mass., Feb. 03, 2025 (GLOBE NEWSWIRE) -- (NASDAQ: OCUL, “Ocular”), a biopharmaceutical company committed to ...

The U.S. Food and Drug Administration has approved Susvimo (ranibizumab) 100 mg/mL for treating diabetic macular edema.

Equities research analysts at StockNews.com initiated coverage on shares of IRIDEX (NASDAQ:IRIX – Get Free Report) in a report issued on Wednesday. The firm set a “hold” rating on the medical ...

Purpose: To assess the sensitivity and specificity of the retinopathy of prematurity score (ROPScore) and weight, insulin-like growth factor-1, retinopathy of prematurity algorithm in predicting the ...